StonvexLoading…
StonvexStonvexStonvexCore line items from UTGN's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $36.49M | $42.35M | $42.65M | $25.30M |
Operating Income | $29.73M | $21.87M | $26.91M | $14.38M |
Net Income | $23.44M | $17.08M | $21.26M | $11.01M |
EPS (Diluted) | $7.42 | $5.42 | $6.74 | $3.49 |
Total Assets | $521.39M | $491.37M | $499.61M | $488.41M |
Total Liabilities | $264.82M | $258.68M | $266.72M | $265.93M |
Cash & Equivalents | $46.77M | $30.54M | $49.45M | $38.38M |
Free Cash Flow OCF − CapEx | Not available | Not available | Not available | Not available |
Shares Outstanding | 3.14M | 3.14M | 3.14M | 3.15M |